Melissa Viray

Preliminary results: surveillance for Guillain-Barré Syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.

C. Prothro, Kathy Kudish, M. Fielline et al. · MMWR Morbidity and Mortality Weekly Report · 2010 · 105 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans

Matthew E. Wise, Melissa Viray, James J. Sejvar et al. · American Journal of Epidemiology · 2012 · 95 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +16

Longitudinal Trends in Antimicrobial Susceptibilities Across Long-Term–Care Facilities: Emergence of Fluoroquinolone Resistance

Melissa Viray, Darren R. Linkin, Joel N. Maslow et al. · Infection Control and Hospital Epidemiology · 2005 · 70 citations

Life Sciences, Infectious Diseases, Microbiology +16

Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ — Hawaii, 2013

David Johnston, Arthur Chang, Melissa Viray et al. · Drug Testing and Analysis · 2015 · 54 citations · Full text

Pharmacy, Nutrition, Toxicology +16

The Risk of Guillain–Barré Syndrome Associated with Influenza A (H1N1) 2009 Monovalent Vaccine and 2009–2010 Seasonal Influenza Vaccines: Results from Self‐Controlled Analyses

Jerome I. Tokars, Paige Lewis, Frank DeStefano et al. · Pharmacoepidemiology and Drug Safety · 2012 · 53 citations

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17